1-13 of 13
Meliha Nalcaci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PAR1 Antagonist Specifically Inhibits Thrombin-Induced PAR1 Activation and Thrombo-Inflammation in Philadelphia Negative Myeloproliferative Neoplasms

Ildeniz Uslu-Bicak, Meliha Nalcaci, Selcuk Sozer
Journal: Blood
Blood (2024) 144 (Supplement 1): 6559.
https://doi.org/10.1182/blood-2024-194445
Published: 2024
Journal Articles

Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

Serkan Guven, Deniz Özmen, Yunus Çatma, Tuba Güllü Koca, Onur Kırkızlar, Ömer Şeker, Sercan Ünal, Seçil Salim, Betül Kübra Tüzün, Aslı Yüksel Öztürkmen, Nergiz Erkut, Esra Kiriktir, Nesibe Taşer Kanat, Püsem Patır, Abdülkadir Karışmaz, Seval Akpınar, Emel Gürkan, Nurcan Özçelik Kürkçü, Öznur Aydın, Gülsüm Çağlıyan, Ayfer Gedük, Süleyman Arslan, Zehra Narlı Özdemir, Rafiye Çiftçiler, Ayşe Uysal, Merve Aydoğan, Yıldız İpek, Merve Ecem Erdoğan Yön, Zeynep Tuğba Karabulut, Emel Bostan, Sinan Mersin, Tarık Onur Tiryaki, Vildan Gürsoy, İrfan Yavaşoğlu, Ali Doğan, Güchan Alanoğlu, Mehmet Baysal, Eren Arslan Davulcu, Ayşe Kaya, İbrahim Ethem Pınar, Abdülkerim Yıldız, Gülşah Akyol, İnci Alacacıoğlu, Mutlu Arat, Mesut Ayer, Meltem Aylı, İlhami Berber, Ahmet Muzaffer Demir, İbrahim Haznedaroğlu, Fehmi Hindilerden, Erdal Kurtoğlu, Meliha Nalçacı, Fahir Özkalemkaş, Vildan Özkocaman, Güray Saydam, Mehmet Sönmez, Selami Koçak Toprak, Tülin Tuğlular, Burhan Turgut, Mehmet Turgut, Ahmet Emre Eskazan
Journal: Blood
Blood (2024) 144 (Supplement 1): 6585.
https://doi.org/10.1182/blood-2024-193433
Published: 2024
Journal Articles

R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Murat Ozbalak, Metban Mastanzade, Ozden Ozluk, Tarik Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, Ipek Yonal Hindilerden, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalcaci, Burhan Ferhanoglu, Sevgi Kalayoglu Besisik
Journal: Blood
Blood (2021) 138 (Supplement 1): 4585.
https://doi.org/10.1182/blood-2021-145810
Published: 2021
Journal Articles

Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data

Osman Ilhan, Guldane Cengiz Seval, Ferit Avcu, MD, Burhan Ferhanoglu, MD, Güven Çetin, Erdal Kurtoglu, Figen Atalay, MD, Emine Gulturk, Meliha Nalcaci, Meral Beksac, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-138899
Published: 2020
Journal Articles

The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study

Mustafa Nuri Yenerel, MD, Simge Erdem, MD, Metban Mastanzade, Meliha Nalcaci
Journal: Blood
Blood (2018) 132 (Supplement 1): 4876.
https://doi.org/10.1182/blood-2018-99-119480
Published: 2018
Journal Articles

The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome

Mustafa Nuri Yenerel, Yasar Caliskan, Alaattin Yildiz, Sedat Karadeniz, Aydin Turkmen, Mehmet Seit Kayacan, Tufan Tukek, Murat Köse, Melih Aktan, Meliha Nalcaci
Journal: Blood
Blood (2017) 130 (Supplement 1): 3618.
https://doi.org/10.1182/blood.V130.Suppl_1.3618.3618
Published: 2017
Journal Articles

Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

Esra Turan Erkek, Esra Nazligul, Meliha Nalcaci, Melih Aktan, Mustafa Nuri Yenerel
Journal: Blood
Blood (2015) 126 (23): 4535.
https://doi.org/10.1182/blood.V126.23.4535.4535
Published: 2015
Journal Articles

The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience

Mustafa Nuri Yenerel, MD, Melih Aktan, Alaattin Yildiz, Yasar Caliskan, Meliha Nalcaci
Journal: Blood
Blood (2014) 124 (21): 2777.
https://doi.org/10.1182/blood.V124.21.2777.2777
Published: 2014
Journal Articles

Prognostic Significance Of ASXL1 and IDH Mutations inPhiladelphia Negative Myeloproliferative Neoplasms

Ipek Yonal, Aynur Daglar Aday, Aysegul Basak Akadam, Ceylan Yilmaz, Meliha Nalcaci, Akif Selim Yavuz, Fatma Deniz Sargin
Journal: Blood
Blood (2013) 122 (21): 5260.
https://doi.org/10.1182/blood.V122.21.5260.5260
Published: 2013
Journal Articles

Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?

Hasan Dermenci, Aynur Daglar, Basak Peker Akadam, Veysel Sabri Hancer, Yusuf Gelmez, Melih Aktan, Meliha Nalcaci, Akif S. Yavuz
Journal: Blood
Blood (2012) 120 (21): 5056.
https://doi.org/10.1182/blood.V120.21.5056.5056
Published: 2012
Journal Articles

Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome

Ipek Yonal, Fehmi Hindilerden, Veysel Sabri Hancer, Bahar Artim Esen, Meliha Nalcaci, Reyhan Diz Kucukkaya
Journal: Blood
Blood (2010) 116 (21): 3171.
https://doi.org/10.1182/blood.V116.21.3171.3171
Published: 2010
Journal Articles

Does Previous Interferon Use Have Negative Effect on Imatinib Response in Chronic Myeloid Leukemia (CML)? A Single Center Study.

Mustafa Yenerel, Reyhan Diz-Kucukkaya, Naciye Demirel, Mesut Ayer, Selim Yavuz, Sevgi Besisik, Melih Aktan, Meliha Nalcaci, Deniz Sargin, Tanju Atamer, Yuksel Pekcelen, Guncag Dincol
Journal: Blood
Blood (2006) 108 (11): 4821.
https://doi.org/10.1182/blood.V108.11.4821.4821
Published: 2006
Journal Articles

CD15-expressing phagocytic plasma cells in a patient with multiple myeloma

Reyhan Diz Kucukkaya, Abdullah Hacihanefioglu, Mustafa Nuri Yenerel, Mehmet Turgut, Meliha Nalcaci, Huseyin Keskin, Seyhun Solakoglu, Gulderen Yanikkaya Demirel
Journal: Blood
Blood (2001) 97 (2): 581–583.
https://doi.org/10.1182/blood.V97.2.581
Published: 2001